These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26704864)

  • 21. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance.
    Denzer C; Thiere D; Muche R; Koenig W; Mayer H; Kratzer W; Wabitsch M
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3872-81. PubMed ID: 19773396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid dysfunction and hepatic steatosis in overweight children and adolescents.
    Kaltenbach TE; Graeter T; Oeztuerk S; Holzner D; Kratzer W; Wabitsch M; Denzer C
    Pediatr Obes; 2017 Feb; 12(1):67-74. PubMed ID: 26877190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Saturated fatty acid intake can influence increase in plasminogen activator inhibitor-1 in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Corgosinho FC; Carnier J; Oyama LM; do Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Horm Metab Res; 2014 Apr; 46(4):245-51. PubMed ID: 24619821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of plasminogen activator inhibitor-1 and fibroblastic growth factor 21 in 3 groups of type 2 diabetes: Without overweight/obesity, free of insulin resistance, and without hepatosteatosis.
    Takebe N; Hasegawa Y; Matsushita Y; Chiba H; Onodera K; Kinno H; Oda T; Nagasawa K; Segawa T; Takahashi Y; Okada K; Ishigaki Y
    Medicine (Baltimore); 2023 Sep; 102(35):e34797. PubMed ID: 37657012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistance.
    Wu S; Gao H; Ma Y; Fu L; Zhang C; Luo X
    Pediatr Diabetes; 2016 Feb; 17(1):53-60. PubMed ID: 25413012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying non-alcoholic fatty liver disease among asymptomatic overweight and obese individuals by clinical and biochemical characteristics.
    Haentjens P; Massaad D; Reynaert H; Peeters E; Van Meerhaeghe A; Vinken S; Poppe K; Velkeniers B
    Acta Clin Belg; 2009; 64(6):483-93. PubMed ID: 20101871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Which obesity index is the most useful marker for predicting hepatic steatosis in children and adolescents with obesity? A cross-sectional study using quantitative magnetic resonance imaging.
    Ko HJ; Woo S; Han J; Kim YM; Lim HJ; Kim MJ; Park YS; Park KH
    Obes Res Clin Pract; 2023; 17(4):335-342. PubMed ID: 37336708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver steatosis in obese prepubertal children: a possible role of insulin resistance.
    D'Adamo E; Impicciatore M; Capanna R; Loredana Marcovecchio M; Masuccio FG; Chiarelli F; Mohn AA
    Obesity (Silver Spring); 2008 Mar; 16(3):677-83. PubMed ID: 18239582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [TNF-alpha and carbohydrate and lipid parameters in overweight and obese children].
    Goral J
    Ann Acad Med Stetin; 2008; 54(2):14-21. PubMed ID: 19374226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI in identifying hepatic steatosis in obese children and relation to ultrasonography and metabolic findings.
    Pozzato C; Radaelli G; Dall'Asta C; Verduci E; Villa A; Villa C; Scaglioni S; Riva E; Pontiroli AE; Cornalba G; Giovannini M
    J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):493-9. PubMed ID: 18852643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level.
    Huang SC; Yang YJ
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):145-50. PubMed ID: 22983378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hepatic steatosis, visceral fat and metabolic alterations in apparently healthy overweight/obese individuals].
    Ryder E; Mijac V; Fernández E; Palazzi N; Morales MC; Connell L; Parra A; Romero M; Fernández N
    Invest Clin; 2014 Mar; 55(1):3-14. PubMed ID: 24758097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of a multidisciplinary intervention program on hepatic adiposity in overweight-obese children: protocol of the EFIGRO study.
    Medrano M; Maiz E; Maldonado-Martín S; Arenaza L; Rodríguez-Vigil B; Ortega FB; Ruiz JR; Larrarte E; Diez-López I; Sarasúa-Miranda A; Tobalina I; Barrenechea L; Pérez-Asenjo J; Kannengiesser S; Manhães-Savio A; Echaniz O; Labayen I
    Contemp Clin Trials; 2015 Nov; 45(Pt B):346-355. PubMed ID: 26408054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.
    Alessi MC; Bastelica D; Mavri A; Morange P; Berthet B; Grino M; Juhan-Vague I
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1262-8. PubMed ID: 12750120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidisciplinary care of obese children and adolescents for one year reduces ectopic fat content in liver and skeletal muscle.
    Fonvig CE; Chabanova E; Ohrt JD; Nielsen LA; Pedersen O; Hansen T; Thomsen HS; Holm JC
    BMC Pediatr; 2015 Dec; 15():196. PubMed ID: 26714769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating growth arrest-specific 6 protein is associated with adiposity, systemic inflammation, and insulin resistance among overweight and obese adolescents.
    Hsiao FC; Lin YF; Hsieh PS; Chu NF; Shieh YS; Hsieh CH; Lee CH; Hung YJ
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E267-74. PubMed ID: 23341490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic steatosis rather than visceral adiposity is more closely associated with insulin resistance in the early stage of obesity.
    Wasada T; Kasahara T; Wada J; Jimba S; Fujimaki R; Nakagami T; Iwamoto Y
    Metabolism; 2008 Jul; 57(7):980-5. PubMed ID: 18555841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The possible role of liver steatosis in defining metabolic syndrome in prepubertal children.
    D'Adamo E; Marcovecchio ML; Giannini C; Capanna R; Impicciatore M; Chiarelli F; Mohn A
    Metabolism; 2010 May; 59(5):671-6. PubMed ID: 19913850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.